A pan-cancer assessment of rb1/tp53 co-mutations

HIGHLIGHTS

• who: Ling Cai et al. from the Medical Center, Dallas, TX, USA Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA have published the article: A Pan-Cancer Assessment of RB1/TP53 Co-Mutations, in the Journal: Cancers 2022, 14, 4199. of /2022/
• what: The authors focus on the RB1/TP53 co-mutation which the authors discovered was the most frequently observed co-mutation across diverse cancer types with particular enrichment in small cell carcinomas neuroendocrine carcinomas and sarcomas. In Figure 1d-f, the authors provide a snapshot of the web . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.